<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35276888</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">529</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu14030529</ELocationID><Abstract><AbstractText>Creatine monohydrate (CrM) is one of the most widely used nutritional supplements among active individuals and athletes to improve high-intensity exercise performance and training adaptations. However, research suggests that CrM supplementation may also serve as a therapeutic tool in the management of some chronic and traumatic diseases. Creatine supplementation has been reported to improve high-energy phosphate availability as well as have antioxidative, neuroprotective, anti-lactatic, and calcium-homoeostatic effects. These characteristics may have a direct impact on mitochondrion's survival and health particularly during stressful conditions such as ischemia and injury. This narrative review discusses current scientific evidence for use or supplemental CrM as a therapeutic agent during conditions associated with mitochondrial dysfunction. Based on this analysis, it appears that CrM supplementation may have a role in improving cellular bioenergetics in several mitochondrial dysfunction-related diseases, ischemic conditions, and injury pathology and thereby could provide therapeutic benefit in the management of these conditions. However, larger clinical trials are needed to explore these potential therapeutic applications before definitive conclusions can be drawn.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Robert Percy</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0003-4247-1006</Identifier><AffiliationInfo><Affiliation>Medical Department, RasenBallsport Leipzig GmbH, 04177 Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Droste</LastName><ForeName>Jan-Niklas</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Medical Department, RasenBallsport Leipzig GmbH, 04177 Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giessing</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Natural and Environmental Sciences, Institute of Sports Science, Universit&#xe4;t Koblenz-Landau, 76829 Landau, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreider</LastName><ForeName>Richard B</ForeName><Initials>RB</Initials><Identifier Source="ORCID">0000-0002-3906-1658</Identifier><AffiliationInfo><Affiliation>Exercise &amp; Sport Nutrition Lab, Human Clinical Research Facility, Department of Health &amp; Kinesiology, Texas A&amp;M University, College Station, TX 77843, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>MU72812GK0</RegistryNumber><NameOfSubstance UI="D003401">Creatine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003401" MajorTopicYN="Y">Creatine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac infarction</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">hypoxia</Keyword><Keyword MajorTopicYN="N">ischemia</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mitochondriopathia</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">noncommunicable disease</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><CoiStatement>R.P.M. received financial support for presenting on creatine at industry sponsored scientific conferences. J.N.D. declares there is no financial and no non-financial conflict of interest. J.G. reports no conflict of interest. R.B.K. has conducted industry sponsored research on creatine, received financial support for presenting on creatine at industry sponsored scientific conferences, and has served as an expert witness on cases related to creatine. Additionally, he serves as Chair of the Scientific Advisory Board for AlzChem who sponsored this special issue.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35276888</ArticleId><ArticleId IdType="pmc">PMC8838971</ArticleId><ArticleId IdType="doi">10.3390/nu14030529</ArticleId><ArticleId IdType="pii">nu14030529</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bonilla D.A., Kreider R.B., Stout J.R., Forero D.A., Kerksick C.M., Roberts M.D., Rawson E.S. Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review. Nutrients. 2021;13:1238. doi: 10.3390/nu13041238.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041238</ArticleId><ArticleId IdType="pmc">PMC8070484</ArticleId><ArticleId IdType="pubmed">33918657</ArticleId></ArticleIdList></Reference><Reference><Citation>Candow D.G., Forbes S.C., Chilibeck P.D., Cornish S.M., Antonio J., Kreider R.B. Effectiveness of Creatine Supplementation on Aging Muscle and Bone: Focus on Falls Prevention and Inflammation. J. Clin. Med. 2019;8:488. doi: 10.3390/jcm8040488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8040488</ArticleId><ArticleId IdType="pmc">PMC6518405</ArticleId><ArticleId IdType="pubmed">30978926</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosnan M.E., Brosnan J.T. The role of dietary creatine. Amino Acids. 2016;48:1785&#x2013;1791. doi: 10.1007/s00726-016-2188-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-016-2188-1</ArticleId><ArticleId IdType="pubmed">26874700</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris R. Creatine in health, medicine and sport: An introduction to a meeting held at Downing College, University of Cambridge, July 2010. Amino Acids. 2011;40:1267. doi: 10.1007/s00726-011-0913-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-011-0913-3</ArticleId><ArticleId IdType="pubmed">21509489</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris R.C., Soderlund K., Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin. Sci. 1992;83:367&#x2013;374. doi: 10.1042/cs0830367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs0830367</ArticleId><ArticleId IdType="pubmed">1327657</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreider R.B., Stout J.R. Creatine in Health and Disease. Nutrients. 2021;13:447. doi: 10.3390/nu13020447.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020447</ArticleId><ArticleId IdType="pmc">PMC7910963</ArticleId><ArticleId IdType="pubmed">33572884</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultman E., Soderlund K., Timmons J.A., Cederblad G., Greenhaff P.L. Muscle creatine loading in men. J. Appl. Physiol. 1996;81:232&#x2013;237. doi: 10.1152/jappl.1996.81.1.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1996.81.1.232</ArticleId><ArticleId IdType="pubmed">8828669</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallimann T., Tokarska-Schlattner M., Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids. 2011;40:1271&#x2013;1296. doi: 10.1007/s00726-011-0877-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-011-0877-3</ArticleId><ArticleId IdType="pmc">PMC3080659</ArticleId><ArticleId IdType="pubmed">21448658</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas J.R., Casuso R.A., Agust&#xed;n P.H., Cogliati S. Stay Fit, Stay Young: Mitochondria in Movement: The Role of Exercise in the New Mitochondrial Paradigm. Oxidative Med. Cell. Longev. 2019;2019:e7058350. doi: 10.1155/2019/7058350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7058350</ArticleId><ArticleId IdType="pmc">PMC6607712</ArticleId><ArticleId IdType="pubmed">31320983</ArticleId></ArticleIdList></Reference><Reference><Citation>Negro M., Avanzato I., D&#x2019;Antona G. Chapter 2.7&#x2014;Creatine in Skeletal Muscle Physiology. In: Nabavi S.M., Silva A.S., editors. Nonvitamin and Nonmineral Nutritional Supplements. Academic Press; Cambridge, MA, USA: 2019. pp. 59&#x2013;68.</Citation></Reference><Reference><Citation>Nelson A.G., Arnall D.A., Kokkonen J., Day R., Evans J. Muscle glycogen supercompensation is enhanced by prior creatine supplementation. Med. Sci. Sports Exerc. 2001;33:1096&#x2013;1100. doi: 10.1097/00005768-200107000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005768-200107000-00005</ArticleId><ArticleId IdType="pubmed">11445755</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarnopolsky M.A., Parise G. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle Nerve. 1999;22:1228&#x2013;1233. doi: 10.1002/(SICI)1097-4598(199909)22:9&lt;1228::AID-MUS9&gt;3.0.CO;2-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199909)22:9&lt;1228::AID-MUS9&gt;3.0.CO;2-6</ArticleId><ArticleId IdType="pubmed">10454718</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna M.J., Morton J., Selig S.E., Snow R.J. Creatine supplementation increases muscle total creatine but not maximal intermittent exercise performance. J. Appl. Physiol. 1999;87:2244&#x2013;2252. doi: 10.1152/jappl.1999.87.6.2244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1999.87.6.2244</ArticleId><ArticleId IdType="pubmed">10601174</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhaff P.L., Bodin K., Soderlund K., Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am. J. Physiol. 1994;266:E725&#x2013;E730. doi: 10.1152/ajpendo.1994.266.5.E725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.1994.266.5.E725</ArticleId><ArticleId IdType="pubmed">8203511</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood M., Kreider R.B., Earnest C.P., Rasmussen C., Almada A. Differences in creatine retention among three nutritional formulations of oral creatine supplements. J. Exerc. Physiol. Online. 2003;6:37&#x2013;43.</Citation></Reference><Reference><Citation>Choi J.K., Kustermann E., Dedeoglu A., Jenkins B.G. Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation. Eur. J. Neurosci. 2009;30:2143&#x2013;2150. doi: 10.1111/j.1460-9568.2009.07015.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2009.07015.x</ArticleId><ArticleId IdType="pmc">PMC2846694</ArticleId><ArticleId IdType="pubmed">19930399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo I.K., Kong S.W., Sung S.M., Hirashima F., Parow A., Hennen J., Cohen B.M., Renshaw P.F. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Res. 2003;123:87&#x2013;100. doi: 10.1016/S0925-4927(03)00046-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4927(03)00046-5</ArticleId><ArticleId IdType="pubmed">12850248</ArticleId></ArticleIdList></Reference><Reference><Citation>Roschel H., Gualano B., Ostojic S.M., Rawson E.S. Creatine Supplementation and Brain Health. Nutrients. 2021;13:586. doi: 10.3390/nu13020586.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020586</ArticleId><ArticleId IdType="pmc">PMC7916590</ArticleId><ArticleId IdType="pubmed">33578876</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolan E., Gualano B., Rawson E.S. Beyond muscle: The effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury. Eur. J. Sport Sci. 2019;19:1&#x2013;14. doi: 10.1080/17461391.2018.1500644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17461391.2018.1500644</ArticleId><ArticleId IdType="pubmed">30086660</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualano B., Rawson E.S., Candow D.G., Chilibeck P.D. Creatine supplementation in the aging population: Effects on skeletal muscle, bone and brain. Amino Acids. 2016;48:1793&#x2013;1805. doi: 10.1007/s00726-016-2239-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-016-2239-7</ArticleId><ArticleId IdType="pubmed">27108136</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson E.S., Venezia A.C. Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids. 2011;40:1349&#x2013;1362. doi: 10.1007/s00726-011-0855-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-011-0855-9</ArticleId><ArticleId IdType="pubmed">21394604</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornish S.M., Chilibeck P.D., Burke D.G. The effect of creatine monohydrate supplementation on sprint skating in ice-hockey players. J. Sports Med. Phys. Fitness. 2006;46:90&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">16596105</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson B., Vladich T., Blanksby B.A. Effects of 4 weeks of creatine supplementation in junior swimmers on freestyle sprint and swim bench performance. J. Strength Cond. Res. 2002;16:485&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">12423175</ArticleId></ArticleIdList></Reference><Reference><Citation>Grindstaff P.D., Kreider R., Bishop R., Wilson M., Wood L., Alexander C., Almada A. Effects of creatine supplementation on repetitive sprint performance and body composition in competitive swimmers. Int. J. Sport Nutr. 1997;7:330&#x2013;346. doi: 10.1123/ijsn.7.4.330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1123/ijsn.7.4.330</ArticleId><ArticleId IdType="pubmed">9407259</ArticleId></ArticleIdList></Reference><Reference><Citation>Juhasz I., Gyore I., Csende Z., Racz L., Tihanyi J. Creatine supplementation improves the anaerobic performance of elite junior fin swimmers. Acta Physiol. Hung. 2009;96:325&#x2013;336. doi: 10.1556/APhysiol.96.2009.3.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/APhysiol.96.2009.3.6</ArticleId><ArticleId IdType="pubmed">19706374</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva A.J., Machado Reis V., Guidetti L., Bessone Alves F., Mota P., Freitas J., Baldari C. Effect of creatine on swimming velocity, body composition and hydrodynamic variables. J. Sports Med. Phys. Fitness. 2007;47:58&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">17369799</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreider R.B., Ferreira M., Wilson M., Grindstaff P., Plisk S., Reinardy J., Cantler E., Almada A.L. Effects of creatine supplementation on body composition, strength, and sprint performance. Med. Sci. Sports Exerc. 1998;30:73&#x2013;82. doi: 10.1097/00005768-199801000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005768-199801000-00011</ArticleId><ArticleId IdType="pubmed">9475647</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone M.H., Sanborn K., Smith L.L., O&#x2019;Bryant H.S., Hoke T., Utter A.C., Johnson R.L., Boros R., Hruby J., Pierce K.C., et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int. J. Sport Nutr. 1999;9:146&#x2013;165. doi: 10.1123/ijsn.9.2.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1123/ijsn.9.2.146</ArticleId><ArticleId IdType="pubmed">10362452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bemben M.G., Bemben D.A., Loftiss D.D., Knehans A.W. Creatine supplementation during resistance training in college football athletes. Med. Sci. Sports Exerc. 2001;33:1667&#x2013;1673. doi: 10.1097/00005768-200110000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005768-200110000-00009</ArticleId><ArticleId IdType="pubmed">11581550</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman J., Ratamess N., Kang J., Mangine G., Faigenbaum A., Stout J. Effect of creatine and beta-alanine supplementation on performance and endocrine responses in strength/power athletes. Int. J. Sport Nutr. Exerc. Metab. 2006;16:430&#x2013;446. doi: 10.1123/ijsnem.16.4.430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1123/ijsnem.16.4.430</ArticleId><ArticleId IdType="pubmed">17136944</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilibeck P.D., Magnus C., Anderson M. Effect of in-season creatine supplementation on body composition and performance in rugby union football players. Appl. Physiol. Nutr. Metab. 2007;32:1052&#x2013;1057. doi: 10.1139/H07-072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/H07-072</ArticleId><ArticleId IdType="pubmed">18059577</ArticleId></ArticleIdList></Reference><Reference><Citation>Claudino J.G., Mezencio B., Amaral S., Zanetti V., Benatti F., Roschel H., Gualano B., Amadio A.C., Serrao J.C. Creatine monohydrate supplementation on lower-limb muscle power in Brazilian elite soccer players. J. Int. Soc. Sports Nutr. 2014;11:32. doi: 10.1186/1550-2783-11-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1550-2783-11-32</ArticleId><ArticleId IdType="pmc">PMC4077550</ArticleId><ArticleId IdType="pubmed">24991195</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerksick C.M., Rasmussen C., Lancaster S., Starks M., Smith P., Melton C., Greenwood M., Almada A., Kreider R. Impact of differing protein sources and a creatine containing nutritional formula after 12 weeks of resistance training. Nutrition. 2007;23:647&#x2013;656. doi: 10.1016/j.nut.2007.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2007.06.015</ArticleId><ArticleId IdType="pubmed">17679046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerksick C.M., Wilborn C.D., Campbell W.I., Harvey T.M., Marcello B.M., Roberts M.D., Parker A.G., Byars A.G., Greenwood L.D., Almada A.L., et al. The effects of creatine monohydrate supplementation with and without D-pinitol on resistance training adaptations. J. Strength Cond. Res. 2009;23:2673&#x2013;2682. doi: 10.1519/JSC.0b013e3181b3e0de.</Citation><ArticleIdList><ArticleId IdType="doi">10.1519/JSC.0b013e3181b3e0de</ArticleId><ArticleId IdType="pubmed">19858753</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvan E., Walker D.K., Simbo S.Y., Dalton R., Levers K., O&#x2019;Connor A., Goodenough C., Barringer N.D., Greenwood M., Rasmussen C., et al. Acute and chronic safety and efficacy of dose dependent creatine nitrate supplementation and exercise performance. J. Int. Soc. Sports Nutr. 2016;13:12. doi: 10.1186/s12970-016-0124-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12970-016-0124-0</ArticleId><ArticleId IdType="pmc">PMC4815124</ArticleId><ArticleId IdType="pubmed">27034623</ArticleId></ArticleIdList></Reference><Reference><Citation>Volek J.S., Kraemer W.J., Bush J.A., Boetes M., Incledon T., Clark K.L., Lynch J.M. Creatine supplementation enhances muscular performance during high-intensity resistance exercise. J. Am. Diet. Assoc. 1997;97:765&#x2013;770. doi: 10.1016/S0002-8223(97)00189-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8223(97)00189-2</ArticleId><ArticleId IdType="pubmed">9216554</ArticleId></ArticleIdList></Reference><Reference><Citation>Volek J.S., Mazzetti S.A., Farquhar W.B., Barnes B.R., Gomez A.L., Kraemer W.J. Physiological responses to short-term exercise in the heat after creatine loading. Med. Sci. Sports Exerc. 2001;33:1101&#x2013;1108. doi: 10.1097/00005768-200107000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005768-200107000-00006</ArticleId><ArticleId IdType="pubmed">11445756</ArticleId></ArticleIdList></Reference><Reference><Citation>Volek J.S., Ratamess N.A., Rubin M.R., Gomez A.L., French D.N., McGuigan M.M., Scheett T.P., Sharman M.J., Hakkinen K., Kraemer W.J. The effects of creatine supplementation on muscular performance and body composition responses to short-term resistance training overreaching. Eur. J. Appl. Physiol. 2004;91:628&#x2013;637. doi: 10.1007/s00421-003-1031-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-003-1031-z</ArticleId><ArticleId IdType="pubmed">14685870</ArticleId></ArticleIdList></Reference><Reference><Citation>Buford T.W., Kreider R.B., Stout J.R., Greenwood M., Campbell B., Spano M., Ziegenfuss T., Lopez H., Landis J., Antonio J. International Society of Sports Nutrition position stand: Creatine supplementation and exercise. J. Int. Soc. Sports Nutr. 2007;4:6. doi: 10.1186/1550-2783-4-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1550-2783-4-6</ArticleId><ArticleId IdType="pmc">PMC2048496</ArticleId><ArticleId IdType="pubmed">17908288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreider R.B., Wilborn C.D., Taylor L., Campbell B., Almada A.L., Collins R., Cooke M., Earnest C.P., Greenwood M., Kalman D.S., et al. ISSN exercise &amp; sport nutrition review: Research &amp; recommendations. J. Int. Soc. Sports Nutr. 2010;7:7. doi: 10.1186/1550-2783-7-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1550-2783-7-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Branch J.D. Effect of creatine supplementation on body composition and performance: A meta-analysis. Int. J. Sport Nutr. Exerc. Metab. 2003;13:198&#x2013;226. doi: 10.1123/ijsnem.13.2.198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1123/ijsnem.13.2.198</ArticleId><ArticleId IdType="pubmed">12945830</ArticleId></ArticleIdList></Reference><Reference><Citation>Devries M.C., Phillips S.M. Creatine supplementation during resistance training in older adults-a meta-analysis. Med. Sci. Sports Exerc. 2014;46:1194&#x2013;1203. doi: 10.1249/MSS.0000000000000220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000000220</ArticleId><ArticleId IdType="pubmed">24576864</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanhers C., Pereira B., Naughton G., Trousselard M., Lesage F.X., Dutheil F. Creatine Supplementation and Lower Limb Strength Performance: A Systematic Review and Meta-Analyses. Sports Med. 2015;45:1285&#x2013;1294. doi: 10.1007/s40279-015-0337-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-015-0337-4</ArticleId><ArticleId IdType="pubmed">25946994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiroth J.B., Bermon S., Andrei S., Dalloz E., Hebuterne X., Dolisi C. Effects of oral creatine supplementation on maximal pedalling performance in older adults. Eur. J. Appl. Physiol. 2001;84:533&#x2013;539. doi: 10.1007/s004210000370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004210000370</ArticleId><ArticleId IdType="pubmed">11482548</ArticleId></ArticleIdList></Reference><Reference><Citation>McMorris T., Mielcarz G., Harris R.C., Swain J.P., Howard A. Creatine supplementation and cognitive performance in elderly individuals. Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn. 2007;14:517&#x2013;528. doi: 10.1080/13825580600788100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13825580600788100</ArticleId><ArticleId IdType="pubmed">17828627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson E.S., Clarkson P.M. Acute creatine supplementation in older men. Int. J. Sports Med. 2000;21:71&#x2013;75. doi: 10.1055/s-2000-8859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2000-8859</ArticleId><ArticleId IdType="pubmed">10683103</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarnopolsky M.A. Potential benefits of creatine monohydrate supplementation in the elderly. Curr. Opin. Clin. Nutr. Metab. Care. 2000;3:497&#x2013;502. doi: 10.1097/00075197-200011000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00075197-200011000-00013</ArticleId><ArticleId IdType="pubmed">11085837</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguiar A.F., Januario R.S., Junior R.P., Gerage A.M., Pina F.L., do Nascimento M.A., Padovani C.R., Cyrino E.S. Long-term creatine supplementation improves muscular performance during resistance training in older women. Eur. J. Appl. Physiol. 2013;113:987&#x2013;996. doi: 10.1007/s00421-012-2514-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-012-2514-6</ArticleId><ArticleId IdType="pubmed">23053133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreider R.B., Kalman D.S., Antonio J., Ziegenfuss T.N., Wildman R., Collins R., Candow D.G., Kleiner S.M., Almada A.L., Lopez H.L. International Society of Sports Nutrition position stand: Safety and efficacy of creatine supplementation in exercise, sport, and medicine. J. Int. Soc. Sports Nutr. 2017;14:18. doi: 10.1186/s12970-017-0173-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12970-017-0173-z</ArticleId><ArticleId IdType="pmc">PMC5469049</ArticleId><ArticleId IdType="pubmed">28615996</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonio J., Candow D.G., Forbes S.C., Gualano B., Jagim A.R., Kreider R.B., Rawson E.S., Smith-Ryan A.E., VanDusseldorp T.A., Willoughby D.S., et al. Common questions and misconceptions about creatine supplementation: What does the scientific evidence really show? J. Int. Soc. Sports Nutr. 2021;18:13. doi: 10.1186/s12970-021-00412-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12970-021-00412-w</ArticleId><ArticleId IdType="pmc">PMC7871530</ArticleId><ArticleId IdType="pubmed">33557850</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand M.D., Nicholls D.G. Assessing mitochondrial dysfunction in cells. Biochem. J. 2011;435:297&#x2013;312. doi: 10.1042/BJ20110162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20110162</ArticleId><ArticleId IdType="pmc">PMC3076726</ArticleId><ArticleId IdType="pubmed">21726199</ArticleId></ArticleIdList></Reference><Reference><Citation>Read C.Y., Calnan R.J. Mitochondrial disease: Beyond etiology unknown. J. Pediatr. Nurs. 2000;15:232&#x2013;241. doi: 10.1053/jpdn.2000.8042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jpdn.2000.8042</ArticleId><ArticleId IdType="pubmed">10969496</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen B.H., Gold D.R. Mitochondrial cytopathy in adults: What we know so far. Clev. Clin. J. Med. 2001;68:625&#x2013;642. doi: 10.3949/ccjm.68.7.625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.68.7.625</ArticleId><ArticleId IdType="pubmed">11453081</ArticleId></ArticleIdList></Reference><Reference><Citation>Giza C.C., Hovda D.A. The Neurometabolic Cascade of Concussion. J. Athl. Train. 2001;36:228&#x2013;235. doi: 10.1227/NEU.0000000000000505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/NEU.0000000000000505</ArticleId><ArticleId IdType="pmc">PMC155411</ArticleId><ArticleId IdType="pubmed">12937489</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean A., Philip J., Arikan G., Opitz B., Sterr A. Potential for use of creatine supplementation following mild traumatic brain injury. Concussion. 2017;2:CNC34. doi: 10.2217/cnc-2016-0016.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/cnc-2016-0016</ArticleId><ArticleId IdType="pmc">PMC6094347</ArticleId><ArticleId IdType="pubmed">30202575</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetz M. The neurophysiology of brain injury. Clin. Neurophysiol. 2004;115:4&#x2013;18. doi: 10.1016/S1388-2457(03)00258-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-2457(03)00258-X</ArticleId><ArticleId IdType="pubmed">14706464</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke N.S., Ouwerkerk R., Adams C.B., Radda G.K., Ledingham J.G., Rajagopalan B. Phosphorus-31 magnetic resonance spectra reveal prolonged intracellular acidosis in the brain following subarachnoid hemorrhage. Proc. Natl. Acad. Sci. USA. 1994;91:1903&#x2013;1907. doi: 10.1073/pnas.91.5.1903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.5.1903</ArticleId><ArticleId IdType="pmc">PMC43272</ArticleId><ArticleId IdType="pubmed">8127903</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Kawagoe J., Yoshida T., Hattori A., Kogure K., Itoyama Y. Ischemic Delayed Neuronal Death. Stroke. 1995;26:1478&#x2013;1489. doi: 10.1161/01.STR.26.8.1478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.26.8.1478</ArticleId><ArticleId IdType="pubmed">7631357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 1995;15:961&#x2013;973. doi: 10.1016/0896-6273(95)90186-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90186-8</ArticleId><ArticleId IdType="pubmed">7576644</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiskum G., Murphy A.N., Beal M.F. Mitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases. J. Cereb. Blood Flow Metab. 1999;19:351&#x2013;369. doi: 10.1097/00004647-199904000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004647-199904000-00001</ArticleId><ArticleId IdType="pubmed">10197505</ArticleId></ArticleIdList></Reference><Reference><Citation>Schinder A.F., Olson E.C., Spitzer N.C., Montal M. Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity. J. Neurosci. 1996;16:6125&#x2013;6133. doi: 10.1523/JNEUROSCI.16-19-06125.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-19-06125.1996</ArticleId><ArticleId IdType="pmc">PMC6579180</ArticleId><ArticleId IdType="pubmed">8815895</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;ard E., Braissant O. Synthesis and transport of creatine in the CNS: Importance for cerebral functions. J. Neurochem. 2010;115:297&#x2013;313. doi: 10.1111/j.1471-4159.2010.06935.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06935.x</ArticleId><ArticleId IdType="pubmed">20796169</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinowitz A.R., Li X., Levin H.S. Sport and nonsport etiologies of mild traumatic brain injury: Similarities and differences. Annu. Rev. Psychol. 2014;65:301&#x2013;331. doi: 10.1146/annurev-psych-010213-115103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-psych-010213-115103</ArticleId><ArticleId IdType="pubmed">24215134</ArticleId></ArticleIdList></Reference><Reference><Citation>Signoretti S., Lazzarino G., Tavazzi B., Vagnozzi R. The pathophysiology of concussion. PM R. 2011;3:S359&#x2013;S368. doi: 10.1016/j.pmrj.2011.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmrj.2011.07.018</ArticleId><ArticleId IdType="pubmed">22035678</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres R.H., Ducray A.D., Schlattner U., Wallimann T., Widmer H.R. Functions and effects of creatine in the central nervous system. Brain Res. Bull. 2008;76:329&#x2013;343. doi: 10.1016/j.brainresbull.2008.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2008.02.035</ArticleId><ArticleId IdType="pubmed">18502307</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualano B., Roschel H., Lancha A.H., Brightbill C.E., Rawson E.S. In sickness and in health: The widespread application of creatine supplementation. Amino Acids. 2012;43:519&#x2013;529. doi: 10.1007/s00726-011-1132-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-011-1132-7</ArticleId><ArticleId IdType="pubmed">22101980</ArticleId></ArticleIdList></Reference><Reference><Citation>Rae C.D., Br&#xf6;er S. Creatine as a booster for human brain function. How might it work? Neurochem. Int. 2015;89:249&#x2013;259. doi: 10.1016/j.neuint.2015.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2015.08.010</ArticleId><ArticleId IdType="pubmed">26297632</ArticleId></ArticleIdList></Reference><Reference><Citation>Perasso L., Spallarossa P., Gandolfo C., Ruggeri P., Balestrino M. Therapeutic Use of Creatine in Brain or Heart Ischemia: Available Data and Future Perspectives. Med. Res. Rev. 2013;33:336&#x2013;363. doi: 10.1002/med.20255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.20255</ArticleId><ArticleId IdType="pubmed">22135003</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Gorman E., Beutner G., Dolder M., Koretsky A.P., Brdiczka D., Wallimann T. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 1997;414:253&#x2013;257. doi: 10.1016/s0014-5793(97)01045-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(97)01045-4</ArticleId><ArticleId IdType="pubmed">9315696</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer L.E., Machado L.B., Santiago A.P., Da-Silva W.S., De Felice F.G., Holub O., Oliveira M.F., Galina A. Mitochondrial creatine kinase activity prevents reactive oxygen species generation: Antioxidant role of mitochondrial kinase-dependent ADP re-cycling activity. J. Biol. Chem. 2006;281:37361&#x2013;37371. doi: 10.1074/jbc.M604123200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M604123200</ArticleId><ArticleId IdType="pubmed">17028195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakellaris G., Kotsiou M., Tamiolaki M., Kalostos G., Tsapaki E., Spanaki M., Spilioti M., Charissis G., Evangeliou A. Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: An open label randomized pilot study. J. Trauma. 2006;61:322&#x2013;329. doi: 10.1097/01.ta.0000230269.46108.d5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ta.0000230269.46108.d5</ArticleId><ArticleId IdType="pubmed">16917445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakellaris G., Nasis G., Kotsiou M., Tamiolaki M., Charissis G., Evangeliou A. Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study. Acta Paediatr. 2008;97:31&#x2013;34. doi: 10.1111/j.1651-2227.2007.00529.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2007.00529.x</ArticleId><ArticleId IdType="pmc">PMC2583396</ArticleId><ArticleId IdType="pubmed">18053002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosa V., Molin&#xe9; T., Somoza R., Paciucci R., Kondoh H., Lleonart M.E. Oxidative stress and cancer: An overview. Ageing Res. Rev. 2013;12:376&#x2013;390. doi: 10.1016/j.arr.2012.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2012.10.004</ArticleId><ArticleId IdType="pubmed">23123177</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolson G.L., Ferreira G., Settineri R., Ellithorpe R.R., Breeding P., Ash M.E. Mitochondrial Dysfunction and Chronic Disease: Treatment with Membrane Lipid Replacement and Other Natural Supplements. In: Oliveira P.J., editor. Mitochondrial Biology and Experimental Therapeutics. Springer International Publishing; Berlin/Heidelberg, Germany: 2018. pp. 499&#x2013;522.</Citation></Reference><Reference><Citation>Newell C., Leduc-Pessah H., Khan A., Shearer J. The Routledge Handbook on Biochemistry of Exercise. Routledge; Abingdon, UK: 2020. Mitochondrial Dysfunction in Chronic Disease.</Citation></Reference><Reference><Citation>Victor M.V., Rocha M., Herance R., Hernandez-Mijares A. Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes. Curr. Pharm. Des. 2011;17:3947&#x2013;3958. doi: 10.2174/138161211798764915.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161211798764915</ArticleId><ArticleId IdType="pubmed">22188447</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard M., Turnbull D.M. Linking the Metabolic State and Mitochondrial DNA in Chronic Disease, Health, and Aging. Diabetes. 2013;62:672&#x2013;678. doi: 10.2337/db12-1203.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db12-1203</ArticleId><ArticleId IdType="pmc">PMC3581215</ArticleId><ArticleId IdType="pubmed">23431006</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieczenik S.R., Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp. Mol. Pathol. 2007;83:84&#x2013;92. doi: 10.1016/j.yexmp.2006.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2006.09.008</ArticleId><ArticleId IdType="pubmed">17239370</ArticleId></ArticleIdList></Reference><Reference><Citation>Madamanchi N.R., Runge M.S. Mitochondrial Dysfunction in Atherosclerosis. Circ. Res. 2007;100:460&#x2013;473. doi: 10.1161/01.RES.0000258450.44413.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000258450.44413.96</ArticleId><ArticleId IdType="pubmed">17332437</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvan D.L., Green N.H., Danesh F.R. The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int. 2017;92:1051&#x2013;1057. doi: 10.1016/j.kint.2017.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2017.05.034</ArticleId><ArticleId IdType="pmc">PMC5667560</ArticleId><ArticleId IdType="pubmed">28893420</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloonan S.M., Kim K., Esteves P., Trian T., Barnes P.J. Mitochondrial dysfunction in lung ageing and disease. Eur. Respir. Rev. 2020;29:157. doi: 10.1183/16000617.0165-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0165-2020</ArticleId><ArticleId IdType="pmc">PMC9488551</ArticleId><ArticleId IdType="pubmed">33060165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei P.Z., Szeto C.C. Mitochondrial dysfunction in diabetic kidney disease. Clin. Chim. Acta. 2019;496:108&#x2013;116. doi: 10.1016/j.cca.2019.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2019.07.005</ArticleId><ArticleId IdType="pubmed">31276635</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansouri A., Gattolliat C.-H., Asselah T. Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases. Gastroenterology. 2018;155:629&#x2013;647. doi: 10.1053/j.gastro.2018.06.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2018.06.083</ArticleId><ArticleId IdType="pubmed">30012333</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T., Wang M., Xiao H., Wei X. Mitochondrial dysfunction and chronic lung disease. Cell Biol. Toxicol. 2019;35:493&#x2013;502. doi: 10.1007/s10565-019-09473-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10565-019-09473-9</ArticleId><ArticleId IdType="pubmed">31119467</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Armada M.J., Riveiro-Naveira R.R., Vaamonde-Garc&#xed;a C., Valc&#xe1;rcel-Ares M.N. Mitochondrial dysfunction and the inflammatory response. Mitochondrion. 2013;13:106&#x2013;118. doi: 10.1016/j.mito.2013.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2013.01.003</ArticleId><ArticleId IdType="pubmed">23333405</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani R., Hirai K., Aliev G., Drew K.L., Nunomura A., Takeda A., Cash A.D., Obrenovich M.E., Perry G., Smith M.A. Role of mitochondrial dysfunction in Alzheimer&#x2019;s disease. J. Neurosci. Res. 2002;70:357&#x2013;360. doi: 10.1002/jnr.10389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10389</ArticleId><ArticleId IdType="pubmed">12391597</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrentino V., Menzies K.J., Auwerx J. Repairing Mitochondrial Dysfunction in Disease. Annu. Rev. Pharmacol. Toxicol. 2018;58:353&#x2013;389. doi: 10.1146/annurev-pharmtox-010716-104908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010716-104908</ArticleId><ArticleId IdType="pubmed">28961065</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrigo J., Simon F., Cabrera D., Vilos C., Cabello-Verrugio C. Mitochondrial Dysfunction in Skeletal Muscle Pathologies. Curr. Protein Pept. Sci. 2019;20:536&#x2013;546. doi: 10.2174/1389203720666190402100902.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203720666190402100902</ArticleId><ArticleId IdType="pubmed">30947668</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash Y.S., Pabelick C.M., Sieck G.C. Mitochondrial Dysfunction in Airway Disease. Chest. 2017;152:618&#x2013;626. doi: 10.1016/j.chest.2017.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2017.03.020</ArticleId><ArticleId IdType="pmc">PMC5812762</ArticleId><ArticleId IdType="pubmed">28336486</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Vegas A., Sanchez-Aguilera P., Krycer J.R., Morales P.E., Monsalves-Alvarez M., Cifuentes M., Rothermel B.A., Lavandero S. Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases? Endocr. Rev. 2020;41:491&#x2013;517. doi: 10.1210/endrev/bnaa005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnaa005</ArticleId><ArticleId IdType="pmc">PMC7255501</ArticleId><ArticleId IdType="pubmed">32179913</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak E.A., Mollen K.P. Mitochondrial dysfunction in inflammatory bowel disease. Front. Cell Dev. Biol. 2015;3:62. doi: 10.3389/fcell.2015.00062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2015.00062</ArticleId><ArticleId IdType="pmc">PMC4589667</ArticleId><ArticleId IdType="pubmed">26484345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballinger S.W. Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 2005;38:1278&#x2013;1295. doi: 10.1016/j.freeradbiomed.2005.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.02.014</ArticleId><ArticleId IdType="pubmed">15855047</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosca M.G., Hoppel C.L. Mitochondrial dysfunction in heart failure. Heart Fail. Rev. 2013;18:607&#x2013;622. doi: 10.1007/s10741-012-9340-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-012-9340-0</ArticleId><ArticleId IdType="pmc">PMC3855291</ArticleId><ArticleId IdType="pubmed">22948484</ArticleId></ArticleIdList></Reference><Reference><Citation>Chistiakov D.A., Shkurat T.P., Melnichenko A.A., Grechko A.V., Orekhov A.N. The role of mitochondrial dysfunction in cardiovascular disease: A brief review. Ann. Med. 2018;50:121&#x2013;127. doi: 10.1080/07853890.2017.1417631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2017.1417631</ArticleId><ArticleId IdType="pubmed">29237304</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Zhang W., Cao Q., Wang Z., Zhao M., Xu L., Zhuang Q. Mitochondrial dysfunction in fibrotic diseases. Cell Death Discov. 2020;6:1&#x2013;14. doi: 10.1038/s41420-020-00316-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-00316-9</ArticleId><ArticleId IdType="pmc">PMC7474731</ArticleId><ArticleId IdType="pubmed">32963808</ArticleId></ArticleIdList></Reference><Reference><Citation>Johri A., Beal M.F. Mitochondrial Dysfunction in Neurodegenerative Diseases. J. Pharmacol. Exp. Ther. 2012;342:619&#x2013;630. doi: 10.1124/jpet.112.192138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.112.192138</ArticleId><ArticleId IdType="pmc">PMC3422529</ArticleId><ArticleId IdType="pubmed">22700435</ArticleId></ArticleIdList></Reference><Reference><Citation>Barot M., Gokulgandhi M.R., Mitra A.K. Mitochondrial Dysfunction in Retinal Diseases. Curr. Eye Res. 2011;36:1069&#x2013;1077. doi: 10.3109/02713683.2011.607536.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02713683.2011.607536</ArticleId><ArticleId IdType="pmc">PMC4516173</ArticleId><ArticleId IdType="pubmed">21978133</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Liu F. Mitochondrial stress: A bridge between mitochondrial dysfunction and metabolic diseases? Cell. Signal. 2011;23:1528&#x2013;1533. doi: 10.1016/j.cellsig.2011.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2011.05.008</ArticleId><ArticleId IdType="pmc">PMC3148404</ArticleId><ArticleId IdType="pubmed">21616143</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S., Booth N.E., McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2009;2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680051</ArticleId><ArticleId IdType="pubmed">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas R.H. Mitochondrial Dysfunction in Aging and Diseases of Aging. Biology. 2019;8:48. doi: 10.3390/biology8020048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology8020048</ArticleId><ArticleId IdType="pmc">PMC6627182</ArticleId><ArticleId IdType="pubmed">31213034</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp G.J. Mitochondrial dysfunction in chronic ischemia and peripheral vascular disease. Mitochondrion. 2004;4:629&#x2013;640. doi: 10.1016/j.mito.2004.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2004.07.017</ArticleId><ArticleId IdType="pubmed">16120420</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberti M.V., Locasale J.W. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem. Sci. 2016;41:211&#x2013;218. doi: 10.1016/j.tibs.2015.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.12.001</ArticleId><ArticleId IdType="pmc">PMC4783224</ArticleId><ArticleId IdType="pubmed">26778478</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science. 2009;324:1029&#x2013;1033. doi: 10.1126/science.1160809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1160809</ArticleId><ArticleId IdType="pmc">PMC2849637</ArticleId><ArticleId IdType="pubmed">19460998</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapelini P.H., Rezin G.T., Cardoso M.R., Ritter C., Klamt F., Moreira J.C.F., Streck E.L., Dal-Pizzol F. Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. Mitochondrion. 2008;8:211&#x2013;218. doi: 10.1016/j.mito.2008.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2008.03.002</ArticleId><ArticleId IdType="pubmed">18417427</ArticleId></ArticleIdList></Reference><Reference><Citation>Moln&#xe1;r A.G., Kun S., S&#xe9;lley E., Kert&#xe9;sz M., Sz&#xe9;lig L., Csontos C., B&#xf6;ddi K., Bog&#xe1;r L., Miseta A., Wittmann I. Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress&#x2014;A Review. Curr. Med. Chem. 2016;23:667&#x2013;685. doi: 10.2174/0929867323666160119094516.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867323666160119094516</ArticleId><ArticleId IdType="pmc">PMC4997921</ArticleId><ArticleId IdType="pubmed">26785996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz G.G., Pacheco Mois&#xe9;s F.P., Mireles-Ram&#xed;rez M., Flores-Alvarado L.J., Gonz&#xe1;lez-Usigli H., S&#xe1;nchez-Gonz&#xe1;lez V.J., S&#xe1;nchez-L&#xf3;pez A.L., S&#xe1;nchez-Romero L., D&#xed;az-Barba E.I., Santoscoy-Guti&#xe9;rrez J.F., et al. Chapter One-Oxidative Stress: Love and Hate History in Central Nervous System. In: Donev R., editor. Advances in Protein Chemistry and Structural Biology. Volume 108. Academic Press; Cambridge, MA, USA: 2017. pp. 1&#x2013;31. Stress and Inflammation in Disorders.</Citation><ArticleIdList><ArticleId IdType="pubmed">28427557</ArticleId></ArticleIdList></Reference><Reference><Citation>Incalza M.A., D&#x2019;Oria R., Natalicchio A., Perrini S., Laviola L., Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vasc. Pharmacol. 2018;100:1&#x2013;19. doi: 10.1016/j.vph.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2017.05.005</ArticleId><ArticleId IdType="pubmed">28579545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pall M.L., Levine S. Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors. Sheng Li Xue Bao. 2015;67:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">25672622</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldogazieva N.T., Mokhosoev I.M., Mel&#x2019;nikova T.I., Porozov Y.B., Terentiev A.A. Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases. Oxidative Med. Cell. Longev. 2019;2019:e3085756. doi: 10.1155/2019/3085756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3085756</ArticleId><ArticleId IdType="pmc">PMC6710759</ArticleId><ArticleId IdType="pubmed">31485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangsbo J. Energy demands in competitive soccer. J. Sports Sci. 1994;12:S5&#x2013;S12. doi: 10.1080/02640414.1994.12059272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02640414.1994.12059272</ArticleId><ArticleId IdType="pubmed">8072065</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeva M.M., Souto G., Blanco N., Donapetry C. Ammonium metabolism in humans. Metabolism. 2012;61:1495&#x2013;1511. doi: 10.1016/j.metabol.2012.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2012.07.007</ArticleId><ArticleId IdType="pubmed">22921946</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutch B.J., Banister E.W. Ammonia metabolism in exercise and fatigue: A review. Med. Sci. Sports Exerc. 1983;15:41&#x2013;50. doi: 10.1249/00005768-198315010-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/00005768-198315010-00009</ArticleId><ArticleId IdType="pubmed">6341752</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan S., Guha M., Kashina A., Avadhani N.G. Mitochondrial Dysfunction and Mitochondrial Dynamics-The Cancer Connection. Biochim. Biophys. Acta. 2017;1858:602&#x2013;614. doi: 10.1016/j.bbabio.2017.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2017.01.004</ArticleId><ArticleId IdType="pmc">PMC5487289</ArticleId><ArticleId IdType="pubmed">28104365</ArticleId></ArticleIdList></Reference><Reference><Citation>Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: Evidence from magnetic resonance spectroscopy research. Mol. Psychiatry. 2005;10:900&#x2013;919. doi: 10.1038/sj.mp.4001711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4001711</ArticleId><ArticleId IdType="pubmed">16027739</ArticleId></ArticleIdList></Reference><Reference><Citation>Devic S. Warburg Effect-a Consequence or the Cause of Carcinogenesis? J. Cancer. 2016;7:817&#x2013;822. doi: 10.7150/jca.14274.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/jca.14274</ArticleId><ArticleId IdType="pmc">PMC4860798</ArticleId><ArticleId IdType="pubmed">27162540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rani V., Deep G., Singh R.K., Palle K., Yadav U.C.S. Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci. 2016;148:183&#x2013;193. doi: 10.1016/j.lfs.2016.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2016.02.002</ArticleId><ArticleId IdType="pubmed">26851532</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepien K.M., Heaton R., Rankin S., Murphy A., Bentley J., Sexton D., Hargreaves I.P. Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders. J. Clin. Med. 2017;6:71. doi: 10.3390/jcm6070071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm6070071</ArticleId><ArticleId IdType="pmc">PMC5532579</ArticleId><ArticleId IdType="pubmed">28753922</ArticleId></ArticleIdList></Reference><Reference><Citation>Mlyn&#xe1;rik V. Introduction to nuclear magnetic resonance. Anal. Biochem. 2017;529:4&#x2013;9. doi: 10.1016/j.ab.2016.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2016.05.006</ArticleId><ArticleId IdType="pubmed">27210513</ArticleId></ArticleIdList></Reference><Reference><Citation>Prost R.W. Magnetic resonance spectroscopy. Med. Phys. 2008;35:4530&#x2013;4544. doi: 10.1118/1.2975225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1118/1.2975225</ArticleId><ArticleId IdType="pubmed">18975700</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning A. Proton and multinuclear magnetic resonance spectroscopy in the human brain at ultra-high field strength: A review. Neuroimage. 2018;168:181&#x2013;198. doi: 10.1016/j.neuroimage.2017.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.07.017</ArticleId><ArticleId IdType="pubmed">28712992</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter D.A., Smith M.A. Magnetic resonance spectroscopy in vivo. J. Biomed. Eng. 1988;10:562&#x2013;568. doi: 10.1016/0141-5425(88)90116-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0141-5425(88)90116-1</ArticleId><ArticleId IdType="pubmed">3070174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolino A., Frye M., Callicott J.H., Mattay V.S., Rakow R., Shelton-Repella J., Post R., Weinberger D.R. Neuronal pathology in the hippocampal area of patients with bipolar disorder: A study with proton magnetic resonance spectroscopic imaging. Biol. Psychiatry. 2003;53:906&#x2013;913. doi: 10.1016/S0006-3223(02)01911-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3223(02)01911-X</ArticleId><ArticleId IdType="pubmed">12742678</ArticleId></ArticleIdList></Reference><Reference><Citation>Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain Metabolic Alterations in Medication-Free Patients with BipolarDisorder. Arch. Gen. Psychiatry. 2004;61:450&#x2013;458. doi: 10.1001/archpsyc.61.5.450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.61.5.450</ArticleId><ArticleId IdType="pubmed">15123489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato T., Takahashi S., Shioiri T., Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J. Affect. Disord. 1992;26:223&#x2013;230. doi: 10.1016/0165-0327(92)90099-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-0327(92)90099-R</ArticleId><ArticleId IdType="pubmed">1479134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato T., Shioiri T., Murashita J., Hamakawa H., Takahashi Y., Inubushi T., Takahashi S. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol. Med. 1995;25:557&#x2013;566. doi: 10.1017/S003329170003347X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003329170003347X</ArticleId><ArticleId IdType="pubmed">7480436</ArticleId></ArticleIdList></Reference><Reference><Citation>Riesberg L.A., Weed S.A., McDonald T.L., Eckerson J.M., Drescher K.M. Beyond muscles: The untapped potential of creatine. Int. Immunopharmacol. 2016;37:31&#x2013;42. doi: 10.1016/j.intimp.2015.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2015.12.034</ArticleId><ArticleId IdType="pmc">PMC4915971</ArticleId><ArticleId IdType="pubmed">26778152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss M., Schulze A. Health implications of creatine: Can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience. 2002;112:243&#x2013;260. doi: 10.1016/S0306-4522(02)00088-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(02)00088-X</ArticleId><ArticleId IdType="pubmed">12044443</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es-Ferreira L., Pinheiro C.H.J., Gerlinger-Romero F., Vitzel K.F., Nachbar R.T., Curi R., Nunes M.T. Short-term creatine supplementation decreases reactive oxygen species content with no changes in expression and activity of antioxidant enzymes in skeletal muscle. Eur. J. Appl. Physiol. 2012;112:3905&#x2013;3911. doi: 10.1007/s00421-012-2378-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-012-2378-9</ArticleId><ArticleId IdType="pubmed">22415102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter D.J., Reddy K.S. Noncommunicable Diseases. N. Engl. J. Med. 2013;369:1336&#x2013;1343. doi: 10.1056/NEJMra1109345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1109345</ArticleId><ArticleId IdType="pubmed">24088093</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Oyarzun D., Bravo-Sagua R., Diaz-Vega A., Aleman L., Chiong M., Garcia L., Bambs C., Troncoso R., Cifuentes M., Morselli E., et al. Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state? Free Radic. Biol. Med. 2018;124:61&#x2013;78. doi: 10.1016/j.freeradbiomed.2018.05.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.05.084</ArticleId><ArticleId IdType="pubmed">29859344</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., Abraham J., Adair T., Aggarwal R., Ahn S.Y., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095&#x2013;2128. doi: 10.1016/S0140-6736(12)61728-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61728-0</ArticleId><ArticleId IdType="pmc">PMC10790329</ArticleId><ArticleId IdType="pubmed">23245604</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray C.J.L., Lopez A.D. Measuring the Global Burden of Disease. N. Engl. J. Med. 2013;369:448&#x2013;457. doi: 10.1056/NEJMra1201534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1201534</ArticleId><ArticleId IdType="pubmed">23902484</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Noncommunicable Diseases: Progress Monitor 2020. World Health Organization; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>Yu E.P.K., Reinhold J., Yu H., Starks L., Uryga A.K., Foote K., Finigan A., Figg N., Pung Y.-F., Logan A., et al. Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness. Arterioscler. Thromb. Vasc. Biol. 2017;37:2322&#x2013;2332. doi: 10.1161/ATVBAHA.117.310042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.117.310042</ArticleId><ArticleId IdType="pmc">PMC5701734</ArticleId><ArticleId IdType="pubmed">28970293</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu S., Ishibashi M., Kumagai S., Wajima T., Hiroi T., Kurihara T., Ishii M., Kiuchi Y. Decreased cardiac mitochondrial tetrahydrobiopterin in a rat model of pressure overload. Int. J. Mol. Med. 2013;31:589&#x2013;596. doi: 10.3892/ijmm.2013.1236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2013.1236</ArticleId><ArticleId IdType="pubmed">23313998</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Mi C., Liu J., Gao F., Long J. Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat. Cardiovasc. Pathol. 2014;23:101&#x2013;106. doi: 10.1016/j.carpath.2013.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2013.11.002</ArticleId><ArticleId IdType="pubmed">24388463</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther T., Tsch&#xf6;pe C., Sterner-Kock A., Westermann D., Heringer-Walther S., Riad A., Nikolic A., Wang Y., Ebermann L., Siems W.-E., et al. Accelerated Mitochondrial Adenosine Diphosphate/Adenosine Triphosphate Transport Improves Hypertension-Induced Heart Disease. Circulation. 2007;115:333&#x2013;344. doi: 10.1161/CIRCULATIONAHA.106.643296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.643296</ArticleId><ArticleId IdType="pubmed">17210842</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu T., Robotham J.L., Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. USA. 2006;103:2653&#x2013;2658. doi: 10.1073/pnas.0511154103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0511154103</ArticleId><ArticleId IdType="pmc">PMC1413838</ArticleId><ArticleId IdType="pubmed">16477035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tormos K.V., Anso E., Hamanaka R.B., Eisenbart J., Joseph J., Kalyanaraman B., Chandel N.S. Mitochondrial Complex III ROS Regulate Adipocyte Differentiation. Cell Metab. 2011;14:537&#x2013;544. doi: 10.1016/j.cmet.2011.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.08.007</ArticleId><ArticleId IdType="pmc">PMC3190168</ArticleId><ArticleId IdType="pubmed">21982713</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodoro J.S., Rolo A.P., Duarte F.V., Sim&#xf5;es A.M., Palmeira C.M. Differential alterations in mitochondrial function induced by a choline-deficient diet: Understanding fatty liver disease progression. Mitochondrion. 2008;8:367&#x2013;376. doi: 10.1016/j.mito.2008.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2008.07.008</ArticleId><ArticleId IdType="pubmed">18765303</ArticleId></ArticleIdList></Reference><Reference><Citation>Galloway C.A., Lee H., Brookes P.S., Yoon Y. Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 2014;307:G632&#x2013;G641. doi: 10.1152/ajpgi.00182.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00182.2014</ArticleId><ArticleId IdType="pmc">PMC4166723</ArticleId><ArticleId IdType="pubmed">25080922</ArticleId></ArticleIdList></Reference><Reference><Citation>Tubbs E., Chanon S., Robert M., Bendridi N., Bidaux G., Chauvin M.-A., Ji-Cao J., Durand C., Gauvrit-Ramette D., Vidal H., et al. Disruption of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Integrity Contributes to Muscle Insulin Resistance in Mice and Humans. Diabetes. 2018;67:636&#x2013;650. doi: 10.2337/db17-0316.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db17-0316</ArticleId><ArticleId IdType="pubmed">29326365</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazakerley D.J., Minard A.Y., Krycer J.R., Thomas K.C., St&#xf6;ckli J., Harney D.J., Burchfield J.G., Maghzal G.J., Caldwell S.T., Hartley R.C., et al. Mitochondrial oxidative stress causes insulin resistance without disrupting oxidative phosphorylation. J. Biol. Chem. 2018;293:7315&#x2013;7328. doi: 10.1074/jbc.RA117.001254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.001254</ArticleId><ArticleId IdType="pmc">PMC5950018</ArticleId><ArticleId IdType="pubmed">29599292</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.J., Lustig M.E., Boyle K.E., Woodlief T.L., Kane D.A., Lin C.-T., Price J.W., Kang L., Rabinovitch P.S., Szeto H.H., et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Investig. 2009;119:573&#x2013;581. doi: 10.1172/JCI37048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI37048</ArticleId><ArticleId IdType="pmc">PMC2648700</ArticleId><ArticleId IdType="pubmed">19188683</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez T., Parra V., Troncoso R., Pennanen C., Contreras-Ferrat A., Vasquez-Trincado C., Morales P.E., Lopez-Crisosto C., Sotomayor-Flores C., Chiong M., et al. Alteration in mitochondrial Ca2+ uptake disrupts insulin signaling in hypertrophic cardiomyocytes. Cell Commun. Signal. 2014;12:68. doi: 10.1186/s12964-014-0068-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-014-0068-4</ArticleId><ArticleId IdType="pmc">PMC4234850</ArticleId><ArticleId IdType="pubmed">25376904</ArticleId></ArticleIdList></Reference><Reference><Citation>Tubbs E., Theurey P., Vial G., Bendridi N., Bravard A., Chauvin M.-A., Ji-Cao J., Zoulim F., Bartosch B., Ovize M., et al. Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Integrity Is Required for Insulin Signaling and Is Implicated in Hepatic Insulin Resistance. Diabetes. 2014;63:3279&#x2013;3294. doi: 10.2337/db13-1751.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-1751</ArticleId><ArticleId IdType="pubmed">24947355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Wakabayashi N., Wakabayashi J., Tamura Y., Song W.-J., Sereda S., Clerc P., Polster B.M., Aja S.M., Pletnikov M.V., et al. The dynamin-related GTPase Opa1 is required for glucose-stimulated ATP production in pancreatic beta cells. Mol. Biol. Cell. 2011;22:2235&#x2013;2245. doi: 10.1091/mbc.e10-12-0933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e10-12-0933</ArticleId><ArticleId IdType="pmc">PMC3128526</ArticleId><ArticleId IdType="pubmed">21551073</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt F., Schultz J., Waterstradt R., Baltrusch S. Drp1 guarding of the mitochondrial network is important for glucose-stimulated insulin secretion in pancreatic beta cells. Biochem. Biophys. Res. Commun. 2016;474:646&#x2013;651. doi: 10.1016/j.bbrc.2016.04.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.04.142</ArticleId><ArticleId IdType="pubmed">27154223</ArticleId></ArticleIdList></Reference><Reference><Citation>Anello M., Lupi R., Spampinato D., Piro S., Masini M., Boggi U., Del Prato S., Rabuazzo A.M., Purrello F., Marchetti P. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia. 2005;48:282&#x2013;289. doi: 10.1007/s00125-004-1627-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-004-1627-9</ArticleId><ArticleId IdType="pubmed">15654602</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuermann-Freestone M., Madsen P.L., Manners D., Blamire A.M., Buckingham R.E., Styles P., Radda G.K., Neubauer S., Clarke K. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation. 2003;107:3040&#x2013;3046. doi: 10.1161/01.CIR.0000072789.89096.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000072789.89096.10</ArticleId><ArticleId IdType="pubmed">12810608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rider O.J., Francis J.M., Ali M.K., Holloway C., Pegg T., Robson M.D., Tyler D., Byrne J., Clarke K., Neubauer S. Effects of catecholamine stress on diastolic function and myocardial energetics in obesity. Circulation. 2012;125:1511&#x2013;1519. doi: 10.1161/CIRCULATIONAHA.111.069518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.069518</ArticleId><ArticleId IdType="pubmed">22368152</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb H.J., Beyerbacht H.P., Van der Laarse A., Stoel B.C., Doornbos J., Van der Wall E.E., De Roos A. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation. 1999;99:2261&#x2013;2267. doi: 10.1161/01.CIR.99.17.2261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.99.17.2261</ArticleId><ArticleId IdType="pubmed">10226091</ArticleId></ArticleIdList></Reference><Reference><Citation>Guescini M., Tiano L., Genova M.L., Polidori E., Silvestri S., Orlando P., Fimognari C., Calcabrini C., Stocchi V., Sestili P. The Combination of Physical Exercise with Muscle-Directed Antioxidants to Counteract Sarcopenia: A Biomedical Rationale for Pleiotropic Treatment with Creatine and Coenzyme Q10. Oxidative Med. Cell. Longev. 2017;2017:e7083049. doi: 10.1155/2017/7083049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7083049</ArticleId><ArticleId IdType="pmc">PMC5632475</ArticleId><ArticleId IdType="pubmed">29123615</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves C.R.R., Filho C.A.A.M., Benatti F.B., Brucki S., Pereira R.M.R., Pinto A.L.d.S., Lima F.R., Roschel H., Gualano B. Creatine Supplementation Associated or Not with Strength Training upon Emotional and Cognitive Measures in Older Women: A Randomized Double-Blind Study. PLoS ONE. 2013;8:e76301. doi: 10.1371/journal.pone.0076301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076301</ArticleId><ArticleId IdType="pmc">PMC3789718</ArticleId><ArticleId IdType="pubmed">24098469</ArticleId></ArticleIdList></Reference><Reference><Citation>Candow D.G., Forbes S.C., Chilibeck P.D., Cornish S.M., Antonio J., Kreider R.B. Variables Influencing the Effectiveness of Creatine Supplementation as a Therapeutic Intervention for Sarcopenia. Front. Nutr. 2019;6:124. doi: 10.3389/fnut.2019.00124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2019.00124</ArticleId><ArticleId IdType="pmc">PMC6696725</ArticleId><ArticleId IdType="pubmed">31448281</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualano B., Macedo A.R., Alves C.R., Roschel H., Benatti F.B., Takayama L., De Sa Pinto A.L., Lima F.R., Pereira R.M. Creatine supplementation and resistance training in vulnerable older women: A randomized double-blind placebo-controlled clinical trial. Exp. Gerontol. 2014;53:7&#x2013;15. doi: 10.1016/j.exger.2014.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2014.02.003</ArticleId><ArticleId IdType="pubmed">24530883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo D.M., Tritto A.C., Da Silva L.R., De Oliveira P.B., Benatti F.B., Roschel H., Nie&#xdf; B., Gualano B., Pereira R.M.R. Effects of long-term low-dose dietary creatine supplementation in older women. Exp. Gerontol. 2015;70:97&#x2013;104. doi: 10.1016/j.exger.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2015.07.012</ArticleId><ArticleId IdType="pubmed">26192975</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto C.L., Botelho P.B., Carneiro J.A., Mota J.F. Impact of creatine supplementation in combination with resistance training on lean mass in the elderly. J. Cach. Sarc. Muscle. 2016;7:413&#x2013;421. doi: 10.1002/jcsm.12094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12094</ArticleId><ArticleId IdType="pmc">PMC4864174</ArticleId><ArticleId IdType="pubmed">27239423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualano B., Artioli G.G., Poortmans J.R., Lancha Junior A.H. Exploring the therapeutic role of creatine supplementation. Amino Acids. 2010;38:31&#x2013;44. doi: 10.1007/s00726-009-0263-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-009-0263-6</ArticleId><ArticleId IdType="pubmed">19253023</ArticleId></ArticleIdList></Reference><Reference><Citation>Candow D.G., Vogt E., Johannsmeyer S., Forbes S.C., Farthing J.P. Strategic creatine supplementation and resistance training in healthy older adults. Appl. Physiol. Nutr. Metab. 2015;40:689&#x2013;694. doi: 10.1139/apnm-2014-0498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/apnm-2014-0498</ArticleId><ArticleId IdType="pubmed">25993883</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sousa M.V., Da Silva Soares D.B., Cara&#xe7;a E.R., Cardoso R. Dietary protein and exercise for preservation of lean mass and perspectives on type 2 diabetes prevention. Exp. Biol. Med. 2019;244:992&#x2013;1004. doi: 10.1177/1535370219861910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370219861910</ArticleId><ArticleId IdType="pmc">PMC6879776</ArticleId><ArticleId IdType="pubmed">31307203</ArticleId></ArticleIdList></Reference><Reference><Citation>Barney B., Beck G.R. Nutrition Interventions in Heart Failure. In: Bisognano J.D., Earley M.B., Baker M.L., editors. Manual of Heart Failure Management. Springer; Berlin/Heidelberg, Germany: 2009. pp. 207&#x2013;217.</Citation></Reference><Reference><Citation>Solis M.Y., Artioli G.G., Gualano B. Potential of Creatine in Glucose Management and Diabetes. Nutrients. 2021;13:570. doi: 10.3390/nu13020570.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020570</ArticleId><ArticleId IdType="pmc">PMC7915263</ArticleId><ArticleId IdType="pubmed">33572228</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualano B., De Salles Painneli V., Roschel H., Artioli G.G., Neves M., De S&#xe1; Pinto A.L., Da Silva M.E.R., Cunha M.R., Otaduy M.C.G., Leite C.D.C., et al. Creatine in type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Med. Sci. Sports Exerc. 2011;43:770&#x2013;778. doi: 10.1249/MSS.0b013e3181fcee7d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0b013e3181fcee7d</ArticleId><ArticleId IdType="pubmed">20881878</ArticleId></ArticleIdList></Reference><Reference><Citation>Earnest C.P., Almada A.L., Mitchell T.L. High-performance capillary electrophoresis-pure creatine monohydrate reduces blood lipids in men and women. Clin. Sci. 1996;91:113&#x2013;118. doi: 10.1042/cs0910113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs0910113</ArticleId><ArticleId IdType="pubmed">8774269</ArticleId></ArticleIdList></Reference><Reference><Citation>Deminice R., De Castro G.S.F., Francisco L.V., Da Silva L.E.C.M., Cardoso J.F.R., Frajacomo F.T.T., Teodoro B.G., Dos Reis Silveira L., Jordao A.A. Creatine supplementation prevents fatty liver in rats fed choline-deficient diet: A burden of one-carbon and fatty acid metabolism. J. Nutr. Biochem. 2015;26:391&#x2013;397. doi: 10.1016/j.jnutbio.2014.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2014.11.014</ArticleId><ArticleId IdType="pubmed">25649792</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Akki A., Wang Y., Leppo M.K., Chacko V.P., Foster D.B., Caceres V., Shi S., Kirk J.A., Su J., et al. Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J. Clin. Investig. 2012;122:291&#x2013;302. doi: 10.1172/JCI57426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57426</ArticleId><ArticleId IdType="pmc">PMC3248286</ArticleId><ArticleId IdType="pubmed">22201686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallis J., Lygate C.A., Fischer A., ten Hove M., Schneider J.E., Sebag-Montefiore L., Dawson D., Hulbert K., Zhang W., Zhang M.H., et al. Supranormal Myocardial Creatine and Phosphocreatine Concentrations Lead to Cardiac Hypertrophy and Heart Failure. Circulation. 2005;112:3131&#x2013;3139. doi: 10.1161/CIRCULATIONAHA.105.572990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.572990</ArticleId><ArticleId IdType="pubmed">16286605</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimben L., Ingwall J.S., Pauletto P., Friedrich J., Gwathmey J.K., Saks V., Pessina A.C., Allen P.d. Creatine Kinase System in Failing and Nonfailing Human Myocardium. Circulation. 1996;94:1894&#x2013;1901. doi: 10.1161/01.CIR.94.8.1894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.94.8.1894</ArticleId><ArticleId IdType="pubmed">8873665</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer S. The Failing Heart&#x2014;An Engine Out of Fuel. N. Engl. J. Med. 2007;356:1140&#x2013;1151. doi: 10.1056/NEJMra063052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra063052</ArticleId><ArticleId IdType="pubmed">17360992</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W., Spindler M., Higgins M.A., Jin N., Gill R.M., Bloem L.J., Ryan T.P., Ingwall J.S. The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: Complex post-transcriptional regulation of the components of the CK system. J. Mol. Cell. Cardiol. 2005;39:537&#x2013;544. doi: 10.1016/j.yjmcc.2005.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2005.05.003</ArticleId><ArticleId IdType="pubmed">15978613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lygate C.A., Fischer A., Sebag-Montefiore L., Wallis J., ten Hove M., Neubauer S. The creatine kinase energy transport system in the failing mouse heart. J. Mol. Cell. Cardiol. 2007;42:1129&#x2013;1136. doi: 10.1016/j.yjmcc.2007.03.899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2007.03.899</ArticleId><ArticleId IdType="pubmed">17481652</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao R., Nascimben L., Friedrich J., Gwathmey J.K., Ingwall J.S. Decreased Energy Reserve in an Animal Model of Dilated Cardiomyopathy. Circ. Res. 1996;78:893&#x2013;902. doi: 10.1161/01.RES.78.5.893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.78.5.893</ArticleId><ArticleId IdType="pubmed">8620610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zervou S., Whittington H.J., Russell A.J., Lygate C.A. Augmentation of Creatine in the Heart. Mini Rev. Med. Chem. 2016;16:19&#x2013;28. doi: 10.2174/1389557515666150722102151.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557515666150722102151</ArticleId><ArticleId IdType="pmc">PMC4634222</ArticleId><ArticleId IdType="pubmed">26202199</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer S., Krahe T., Schindler R., Horn M., Hillenbrand H., Entzeroth C., Mader H., Kromer E.P., Riegger G.A., Lackner K. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810&#x2013;1818. doi: 10.1161/01.CIR.86.6.1810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.86.6.1810</ArticleId><ArticleId IdType="pubmed">1451253</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer S., Horn M., Pabst T., G&#xf6;dde M., L&#xfc;bke D., Jilling B., Hahn D., Ertl G. Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease. Eur. Heart J. 1995;16:115&#x2013;118. doi: 10.1093/eurheartj/16.suppl_O.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/16.suppl_O.115</ArticleId><ArticleId IdType="pubmed">8682076</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer S., Horn M., Cramer M., Harre K., Newell J.B., Peters W., Pabst T., Ertl G., Hahn D., Ingwall J.S., et al. Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients with Dilated Cardiomyopathy. Circulation. 1997;96:2190&#x2013;2196. doi: 10.1161/01.CIR.96.7.2190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.96.7.2190</ArticleId><ArticleId IdType="pubmed">9337189</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn M., Remkes H., Dienesch C., Hu K., Ertl G., Neubauer S. Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction. Cardiovasc. Res. 1999;43:117&#x2013;124. doi: 10.1016/S0008-6363(99)00075-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(99)00075-9</ArticleId><ArticleId IdType="pubmed">10536696</ArticleId></ArticleIdList></Reference><Reference><Citation>McClung J., Hand G., Davis J., Carson J. Effect of creatine supplementation on cardiac muscle of exercise-stressed rats. Eur. J. Appl. Physiol. 2003;89:26&#x2013;33. doi: 10.1007/s00421-002-0746-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-002-0746-6</ArticleId><ArticleId IdType="pubmed">12627302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo H., Jiang N., Ma G., Qu J., Zhang G., Cao D., Wen L., Liu S., Ji L.L., Zhang Y. Regulation of mitochondrial uncoupling respiration during exercise in rat heart: Role of reactive oxygen species (ROS) and uncoupling protein 2. Free Radic. Biol. Med. 2008;44:1373&#x2013;1381. doi: 10.1016/j.freeradbiomed.2007.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2007.12.033</ArticleId><ArticleId IdType="pubmed">18226608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao F., Zervou S., Lygate C.A. The creatine kinase system as a therapeutic target for myocardial ischaemia&#x2013;reperfusion injury. Biochem. Soc. Trans. 2018;46:1119&#x2013;1127. doi: 10.1042/BST20170504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20170504</ArticleId><ArticleId IdType="pmc">PMC6195634</ArticleId><ArticleId IdType="pubmed">30242115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultman J., Ronquist G., Forsberg J.O., Hansson H.E. Myocardial energy restoration of ischemic damage by administration of phosphoenolpyruvate during reperfusion. A study in a paracorporeal rat heart model. Eur. Surg. Res. 1983;15:200&#x2013;207. doi: 10.1159/000128354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000128354</ArticleId><ArticleId IdType="pubmed">6873118</ArticleId></ArticleIdList></Reference><Reference><Citation>Osbakken M., Ito K., Zhang D., Ponomarenko I., Ivanics T., Jahngen E.G., Cohn M. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart. Cardiology. 1992;80:184&#x2013;195. doi: 10.1159/000175002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000175002</ArticleId><ArticleId IdType="pubmed">1511465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharov V.G., Saks V.A., Kupriyanov V.V., Lakomkin V.L., Kapelko V.I., Steinschneider A.Y., Javadov S.A. Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studies. J. Thorac. Cardiovasc. Surg. 1987;94:749&#x2013;761. doi: 10.1016/S0022-5223(19)36191-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)36191-4</ArticleId><ArticleId IdType="pubmed">3669703</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrino M., Sarocchi M., Adriano E., Spallarossa P. Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. Amino Acids. 2016;48:1955&#x2013;1967. doi: 10.1007/s00726-016-2173-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-016-2173-8</ArticleId><ArticleId IdType="pubmed">26795537</ArticleId></ArticleIdList></Reference><Reference><Citation>ten Hove M., Lygate C.A., Fischer A., Schneider J.E., Sang A.E., Hulbert K., Sebag-Montefiore L., Watkins H., Clarke K., Isbrandt D., et al. Reduced Inotropic Reserve and Increased Susceptibility to Cardiac Ischemia/Reperfusion Injury in Phosphocreatine-Deficient Guanidinoacetate-N-Methyltransferase&#x2013;Knockout Mice. Circulation. 2005;111:2477&#x2013;2485. doi: 10.1161/01.CIR.0000165147.99592.01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000165147.99592.01</ArticleId><ArticleId IdType="pubmed">15883212</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgebaly S.A., Wei Z., Tyles E., Elkerm A.F., Houser S.L., Gillies C., Kaddurah-Daouk R. Enhancement of the recovery of rat hearts after prolonged cold storage by cyclocreatine phosphate. Transplantation. 1994;57:803&#x2013;806. doi: 10.1097/00007890-199403270-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007890-199403270-00005</ArticleId><ArticleId IdType="pubmed">8154024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cisowski M., Bochenek A., Kucewicz E., Wnuk-Wojnar A.M., Morawski W., Skalski J., Grzybek H. The use of exogenous creatine phosphate for myocardial protection in patients undergoing coronary artery bypass surgery. J. Cardiovasc. Surg. 1996;37:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">10064355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruda M.Y., Samarenko M.B., Afonskaya N.I., Saks V.A. Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction. Am. Heart J. 1988;116:393&#x2013;397. doi: 10.1016/0002-8703(88)90611-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(88)90611-4</ArticleId><ArticleId IdType="pubmed">2456682</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgebaly S.A., Poston R., Todd R., Helmy T., Almaghraby A.M., Elbayoumi T., Kreutzer D.L. Cyclocreatine protects against ischemic injury and enhances cardiac recovery during early reperfusion. Expert Rev. Cardiovasc. Ther. 2019;17:683&#x2013;697. doi: 10.1080/14779072.2019.1662722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14779072.2019.1662722</ArticleId><ArticleId IdType="pubmed">31483166</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts J.J., Walker J.B. Feeding a creatine analogue delays ATP depletion and onset of rigor in ischemic heart. Am. J. Physiol. Heart Circ. Physiol. 1982;243:H911&#x2013;H916. doi: 10.1152/ajpheart.1982.243.6.H911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1982.243.6.H911</ArticleId><ArticleId IdType="pubmed">7149044</ArticleId></ArticleIdList></Reference><Reference><Citation>Chida K., Otani H., Kohzuki M., Saito H., Kagaya Y., Takai Y., Takahashi S., Yamada S., Zuguchi M. The Relationship between Plasma BNP Level and the Myocardial Phosphocreatine/Adenosine Triphosphate Ratio Determined by Phosphorus-31 Magnetic Resonance Spectroscopy in Patients with Dilated Cardiomyopathy. Cardiology. 2006;106:132&#x2013;136. doi: 10.1159/000092767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000092767</ArticleId><ArticleId IdType="pubmed">16636542</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo E., Nguyen H., Lippert T., Tuazon J., Borlongan C.V., Napoli E. Mitochondrial targeting as a novel therapy for stroke. Brain Circ. 2018;4:84&#x2013;94. doi: 10.4103/bc.bc_14_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/bc.bc_14_18</ArticleId><ArticleId IdType="pmc">PMC6187947</ArticleId><ArticleId IdType="pubmed">30450413</ArticleId></ArticleIdList></Reference><Reference><Citation>Soustiel J.F., Zaaroor M. Mitochondrial targeting for development of novel drug strategies in brain injury. Cent. Nerv. Syst. Agents Med. Chem. 2012;12:131&#x2013;145. doi: 10.2174/187152412800792661.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152412800792661</ArticleId><ArticleId IdType="pubmed">22530837</ArticleId></ArticleIdList></Reference><Reference><Citation>Niizuma K., Endo H., Chan P.H. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J. Neurochem. 2009;109:133&#x2013;138. doi: 10.1111/j.1471-4159.2009.05897.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.05897.x</ArticleId><ArticleId IdType="pmc">PMC2679225</ArticleId><ArticleId IdType="pubmed">19393019</ArticleId></ArticleIdList></Reference><Reference><Citation>Niizuma K., Yoshioka H., Chen H., Kim G.S., Jung J.E., Katsu M., Okami N., Chan P.H. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim. Biophys. Acta (BBA) Mol. Basis Dis. 2010;1802:92&#x2013;99. doi: 10.1016/j.bbadis.2009.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.09.002</ArticleId><ArticleId IdType="pmc">PMC2790539</ArticleId><ArticleId IdType="pubmed">19751828</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787&#x2013;795. doi: 10.1038/nature05292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05292</ArticleId><ArticleId IdType="pubmed">17051205</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z., Ning N., Zhou Q., Khoshnam S.E., Farzaneh M. Mitochondria as a therapeutic target for ischemic stroke. Free Radic. Biol. Med. 2020;146:45&#x2013;58. doi: 10.1016/j.freeradbiomed.2019.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.11.005</ArticleId><ArticleId IdType="pubmed">31704373</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H., Zarriello S., Rajani M., Tuazon J., Napoli E., Borlongan C.V. Understanding the Role of Dysfunctional and Healthy Mitochondria in Stroke Pathology and Its Treatment. Int. J. Mol. Sci. 2018;19:2127. doi: 10.3390/ijms19072127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19072127</ArticleId><ArticleId IdType="pmc">PMC6073421</ArticleId><ArticleId IdType="pubmed">30037107</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson T.H., Reynolds C.A., Kumar R., Przyklenk K., H&#xfc;ttemann M. Molecular Mechanisms of Ischemia&#x2013;Reperfusion Injury in Brain: Pivotal Role of the Mitochondrial Membrane Potential in Reactive Oxygen Species Generation. Mol. Neurobiol. 2013;47:9&#x2013;23. doi: 10.1007/s12035-012-8344-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-012-8344-z</ArticleId><ArticleId IdType="pmc">PMC3725766</ArticleId><ArticleId IdType="pubmed">23011809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouchani E.T., Pell V.R., James A.M., Work L.M., Saeb-Parsy K., Frezza C., Krieg T., Murphy M.P. A Unifying Mechanism for Mitochondrial Superoxide Production during Ischemia-Reperfusion Injury. Cell Metab. 2016;23:254&#x2013;263. doi: 10.1016/j.cmet.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.12.009</ArticleId><ArticleId IdType="pubmed">26777689</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrabi S.S., Parvez S., Tabassum H. Ischemic stroke and mitochondria: Mechanisms and targets. Protoplasma. 2020;257:335&#x2013;343. doi: 10.1007/s00709-019-01439-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00709-019-01439-2</ArticleId><ArticleId IdType="pubmed">31612315</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls D.G. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim. Biophys. Acta. 2009;1787:1416&#x2013;1424. doi: 10.1016/j.bbabio.2009.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2009.03.010</ArticleId><ArticleId IdType="pmc">PMC2752662</ArticleId><ArticleId IdType="pubmed">19298790</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K., Hardy J., Zetterberg H. The neuropathology and neurobiology of traumatic brain injury. Neuron. 2012;76:886&#x2013;899. doi: 10.1016/j.neuron.2012.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.11.021</ArticleId><ArticleId IdType="pubmed">23217738</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner C.E., Byblow W.D., Gant N. Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation. J. Neurosci. 2015;35:1773&#x2013;1780. doi: 10.1523/JNEUROSCI.3113-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3113-14.2015</ArticleId><ArticleId IdType="pmc">PMC6795258</ArticleId><ArticleId IdType="pubmed">25632150</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Li M., Figueroa B.E., Liu A., Stavrovskaya I.G., Pasinelli P., Beal M.F., Brown R.H., Kristal B.S., Ferrante R.J., et al. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J. Neurosci. 2004;24:5909&#x2013;5912. doi: 10.1523/JNEUROSCI.1278-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1278-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729248</ArticleId><ArticleId IdType="pubmed">15229238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausmann O.N., Fouad K., Wallimann T., Schwab M.E. Protective effects of oral creatine supplementation on spinal cord injury in rats. Spin. Cord. 2002;40:449&#x2013;456. doi: 10.1038/sj.sc.3101330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.sc.3101330</ArticleId><ArticleId IdType="pubmed">12185606</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan P.G., Geiger J.D., Mattson M.P., Scheff S.W. Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol. 2000;48:723&#x2013;729. doi: 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W</ArticleId><ArticleId IdType="pubmed">11079535</ArticleId></ArticleIdList></Reference><Reference><Citation>Prass K., Royl G., Lindauer U., Freyer D., Megow D., Dirnagl U., St&#xf6;ckler-Ipsiroglu G., Wallimann T., Priller J. Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J. Cereb. Blood Flow Metab. 2007;27:452&#x2013;459. doi: 10.1038/sj.jcbfm.9600351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jcbfm.9600351</ArticleId><ArticleId IdType="pubmed">16773141</ArticleId></ArticleIdList></Reference><Reference><Citation>Freire Royes L.F., Cassol G. The Effects of Creatine Supplementation and Physical Exercise on Traumatic Brain Injury. Mini Rev. Med. Chem. 2016;16:29&#x2013;39. doi: 10.2174/1389557515666150722101926.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557515666150722101926</ArticleId><ArticleId IdType="pubmed">26202200</ArticleId></ArticleIdList></Reference><Reference><Citation>Novelli A., Reilly J.A., Lysko P.G., Henneberry R.C. Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced. Brain Res. 1988;451:205&#x2013;212. doi: 10.1016/0006-8993(88)90765-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(88)90765-2</ArticleId><ArticleId IdType="pubmed">2472189</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji K., Nakamura Y., Ogata T., Shibata T., Kataoka K. Rapid decrease in ATP content without recovery phase during glutamate-induced cell death in cultured spinal neurons. Brain Res. 1994;662:289&#x2013;292. doi: 10.1016/0006-8993(94)90828-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(94)90828-1</ArticleId><ArticleId IdType="pubmed">7859087</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter A.J., M&#xfc;ller R.E., Pschorn U., Stransky W. Preincubation with Creatine Enhances Levels of Creatine Phosphate and Prevents Anoxic Damage in Rat Hippocampal Slices. J. Neurochem. 1995;64:2691&#x2013;2699. doi: 10.1046/j.1471-4159.1995.64062691.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1995.64062691.x</ArticleId><ArticleId IdType="pubmed">7760049</ArticleId></ArticleIdList></Reference><Reference><Citation>Brustovetsky N., Brustovetsky T., Dubinsky J.M. On the mechanisms of neuroprotection by creatine and phosphocreatine. J. Neurochem. 2001;76:425&#x2013;434. doi: 10.1046/j.1471-4159.2001.00052.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00052.x</ArticleId><ArticleId IdType="pubmed">11208905</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman D. The aging process. Proc. Natl. Acad. Sci. USA. 1981;78:7124&#x2013;7128. doi: 10.1073/pnas.78.11.7124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.78.11.7124</ArticleId><ArticleId IdType="pmc">PMC349208</ArticleId><ArticleId IdType="pubmed">6947277</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm A., Friedland K., Eckert A. Mitochondrial dysfunction: The missing link between aging and sporadic Alzheimer&#x2019;s disease. Biogerontology. 2016;17:281&#x2013;296. doi: 10.1007/s10522-015-9618-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-015-9618-4</ArticleId><ArticleId IdType="pubmed">26468143</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuner K., Hauptmann S., Abdel-Kader R., Scherping I., Keil U., Strosznajder J.B., Eckert A., M&#xfc;ller W.E. Mitochondrial dysfunction: The first domino in brain aging and Alzheimer&#x2019;s disease? Antiox. Redox Signal. 2007;9:1659&#x2013;1675. doi: 10.1089/ars.2007.1763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2007.1763</ArticleId><ArticleId IdType="pubmed">17867931</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop N.A., Lu T., Yankner B.A. Neural mechanisms of ageing and cognitive decline. Nature. 2010;464:529&#x2013;535. doi: 10.1038/nature08983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08983</ArticleId><ArticleId IdType="pmc">PMC2927852</ArticleId><ArticleId IdType="pubmed">20336135</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm A., Eckert A. Brain aging and neurodegeneration: From a mitochondrial point of view. J. Neurochem. 2017;143:418&#x2013;431. doi: 10.1111/jnc.14037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14037</ArticleId><ArticleId IdType="pmc">PMC5724505</ArticleId><ArticleId IdType="pubmed">28397282</ArticleId></ArticleIdList></Reference><Reference><Citation>Geary D.C. Mitochondrial Functioning and the Relations among Health, Cognition, and Aging: Where Cell Biology Meets Cognitive Science. Int. J. Mol. Sci. 2021;22:3562. doi: 10.3390/ijms22073562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073562</ArticleId><ArticleId IdType="pmc">PMC8037956</ArticleId><ArticleId IdType="pubmed">33808109</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Reyes R.E., Aliev G., &#xc1;vila-Rodrigues M., Barreto G.E. Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia. Curr. Pharm. Des. 2016;22:812&#x2013;818. doi: 10.2174/1381612822666151209152013.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666151209152013</ArticleId><ArticleId IdType="pubmed">26648470</ArticleId></ArticleIdList></Reference><Reference><Citation>Shieh J.C.-C., Huang P.-T., Lin Y.-F. Alzheimer&#x2019;s Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies. Mol. Neurobiol. 2020;57:1966&#x2013;1977. doi: 10.1007/s12035-019-01858-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01858-5</ArticleId><ArticleId IdType="pubmed">31900863</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Yan Z., Zhou T., Wang G. SIRT1 Regulates Cognitive Performance and Ability of Learning and Memory in Diabetic and Nondiabetic Models. J. Diabetes. Res. 2017;2017:7121827. doi: 10.1155/2017/7121827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7121827</ArticleId><ArticleId IdType="pmc">PMC5661098</ArticleId><ArticleId IdType="pubmed">29164153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo D., Kim B.C., Cho K.A., Song J. The Cerebral Effect of Ammonia in Brain Aging: Blood-Brain Barrier Breakdown, Mitochondrial Dysfunction, and Neuroinflammation. J. Clin. Med. 2021;10:2773. doi: 10.3390/jcm10132773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132773</ArticleId><ArticleId IdType="pmc">PMC8268635</ArticleId><ArticleId IdType="pubmed">34202669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustamante J., Czerniczyniec A., Lores-Arnaiz S. Brain nitric oxide synthases and mitochondrial function. Front. Biosci. 2007;12:1034&#x2013;1040. doi: 10.2741/2123.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2123</ArticleId><ArticleId IdType="pubmed">17127358</ArticleId></ArticleIdList></Reference><Reference><Citation>Felipo V., Butterworth R.F. Mitochondrial dysfunction in acute hyperammonemia. Neurochem. Int. 2002;40:487&#x2013;491. doi: 10.1016/S0197-0186(01)00119-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-0186(01)00119-X</ArticleId><ArticleId IdType="pubmed">11850105</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Monte S.M., Wands J.R. Alzheimer&#x2019;s Disease is Type 3 Diabetes&#x2014;Evidence Reviewed. J. Diabetes Sci. Technol. 2008;2:1101&#x2013;1113. doi: 10.1177/193229680800200619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/193229680800200619</ArticleId><ArticleId IdType="pmc">PMC2769828</ArticleId><ArticleId IdType="pubmed">19885299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sripetchwandee J., Chattipakorn N., Chattipakorn S.C. Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia. Front. Endocrinol. 2018;9:496. doi: 10.3389/fendo.2018.00496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00496</ArticleId><ArticleId IdType="pmc">PMC6127253</ArticleId><ArticleId IdType="pubmed">30233495</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller W.E., Eckert A., Kurz C., Eckert G.P., Leuner K. Mitochondrial dysfunction: Common final pathway in brain aging and Alzheimer&#x2019;s disease&#x2014;Therapeutic aspects. Mol. Neurobiol. 2010;41:159&#x2013;171. doi: 10.1007/s12035-010-8141-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-010-8141-5</ArticleId><ArticleId IdType="pubmed">20461558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaliszewska A., Allison J., Martini M., Arias N. The Interaction of Diet and Mitochondrial Dysfunction in Aging and Cognition. Int. J. Mol. Sci. 2021;22:3574. doi: 10.3390/ijms22073574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073574</ArticleId><ArticleId IdType="pmc">PMC8036520</ArticleId><ArticleId IdType="pubmed">33808221</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis H.M., Stevenson R.J. Potential for diet to prevent and remediate cognitive deficits in neurological disorders. Nutr. Rev. 2018;76:204&#x2013;217. doi: 10.1093/nutrit/nux073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nux073</ArticleId><ArticleId IdType="pubmed">29346658</ArticleId></ArticleIdList></Reference><Reference><Citation>Head E. Oxidative damage and cognitive dysfunction: Antioxidant treatments to promote healthy brain aging. Neurochem. Res. 2009;34:670&#x2013;678. doi: 10.1007/s11064-008-9808-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-008-9808-4</ArticleId><ArticleId IdType="pmc">PMC4392815</ArticleId><ArticleId IdType="pubmed">18683046</ArticleId></ArticleIdList></Reference><Reference><Citation>Poddar J., Pradhan M., Ganguly G., Chakrabarti S. Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements. J. Chem. Neuroanat. 2019;95:70&#x2013;80. doi: 10.1016/j.jchemneu.2018.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2018.04.002</ArticleId><ArticleId IdType="pubmed">29678666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammett S.T., Wall M.B., Edwards T.C., Smith A.T. Dietary supplementation of creatine monohydrate reduces the human fMRI BOLD signal. Neurosci. Lett. 2010;479:201&#x2013;205. doi: 10.1016/j.neulet.2010.05.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2010.05.054</ArticleId><ArticleId IdType="pubmed">20570601</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Kato N., Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci. Res. 2002;42:279&#x2013;285. doi: 10.1016/S0168-0102(02)00007-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-0102(02)00007-X</ArticleId><ArticleId IdType="pubmed">11985880</ArticleId></ArticleIdList></Reference><Reference><Citation>McMorris T., Harris R.C., Howard A.N., Langridge G., Hall B., Corbett J., Dicks M., Hodgson C. Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior. Physiol. Behav. 2007;90:21&#x2013;28. doi: 10.1016/j.physbeh.2006.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2006.08.024</ArticleId><ArticleId IdType="pubmed">17046034</ArticleId></ArticleIdList></Reference><Reference><Citation>Dworak M., Kim T., McCarley R.W., Basheer R. Creatine supplementation reduces sleep need and homeostatic sleep pressure in rats. J. Sleep Res. 2017;26:377&#x2013;385. doi: 10.1111/jsr.12523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.12523</ArticleId><ArticleId IdType="pmc">PMC5435551</ArticleId><ArticleId IdType="pubmed">28397310</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson G.E., Starkov A., Blass J.P., Ratan R.R., Beal M.F. Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim. Biophys. Acta. 2010;1802:122&#x2013;134. doi: 10.1016/j.bbadis.2009.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.08.010</ArticleId><ArticleId IdType="pmc">PMC2790547</ArticleId><ArticleId IdType="pubmed">19715758</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenti D., De Bari L., De Filippis B., Henrion-Caude A., Vacca R.A. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: An overview of Down syndrome, autism, Fragile X and Rett syndrome. Neurosci. Biobehav. Rev. 2014;46:202&#x2013;217. doi: 10.1016/j.neubiorev.2014.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2014.01.012</ArticleId><ArticleId IdType="pubmed">24548784</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhihetty P.J., Beal M.F. Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromol. Med. 2008;10:275&#x2013;290. doi: 10.1007/s12017-008-8053-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-008-8053-y</ArticleId><ArticleId IdType="pmc">PMC2886719</ArticleId><ArticleId IdType="pubmed">19005780</ArticleId></ArticleIdList></Reference><Reference><Citation>Kley R.A., Tarnopolsky M.A., Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst. Rev. 2013;2013:CD004760. doi: 10.1002/14651858.CD004760.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004760.pub4</ArticleId><ArticleId IdType="pmc">PMC6492334</ArticleId><ArticleId IdType="pubmed">23740606</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao A., Lin D., Wang L., Tu S., Lenahan C., Zhang J. Oxidative Stress at the Crossroads of Aging, Stroke and Depression. Aging Dis. 2020;11:1537&#x2013;1566. doi: 10.14336/AD.2020.0225.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0225</ArticleId><ArticleId IdType="pmc">PMC7673857</ArticleId><ArticleId IdType="pubmed">33269106</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E.I., Ressler K.J., Binder E., Nemeroff C.B. The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology. Psychiatr. Clin. 2009;32:549&#x2013;575. doi: 10.1016/j.psc.2009.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psc.2009.05.004</ArticleId><ArticleId IdType="pmc">PMC3684250</ArticleId><ArticleId IdType="pubmed">19716990</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz-Yesiloglu A., Ankerst D.P. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis. Psychiatry Res. Neuroimag. 2006;147:1&#x2013;25. doi: 10.1016/j.pscychresns.2005.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pscychresns.2005.12.004</ArticleId><ArticleId IdType="pubmed">16806850</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaglia F. The role of mitochondrial dysfunction in psychiatric disease. Dev. Disabil. Res. Rev. 2010;16:136&#x2013;143. doi: 10.1002/ddrr.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ddrr.115</ArticleId><ArticleId IdType="pubmed">20818728</ArticleId></ArticleIdList></Reference><Reference><Citation>Agren H., Niklasson F. Creatinine and creatine in CSF: Indices of brain energy metabolism in depression. Short note. J. Neural. Transm. 1988;74:55&#x2013;59. doi: 10.1007/BF01243575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01243575</ArticleId><ArticleId IdType="pubmed">3171573</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza Y., O&#x2019;Neill J., Smith E.A., Russell A., Smith J.M., Banerjee S.P., Bhandari R., Boyd C., Rose M., Ivey J., et al. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. J. Child Neurol. 2006;21:106&#x2013;111. doi: 10.1177/08830738060210020201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08830738060210020201</ArticleId><ArticleId IdType="pubmed">16566872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E., Hall K.H., Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 &#x201c;long-haulers&#x201d;? Chronic Dis. Transl. Med. 2021;7:14&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Frye M.A., Watzl J., Banakar S., O&#x2019;Neill J., Mintz J., Davanzo P., Fischer J., Chirichigno J.W., Ventura J., Elman S., et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology. 2007;32:2490&#x2013;2499. doi: 10.1038/sj.npp.1301387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.npp.1301387</ArticleId><ArticleId IdType="pubmed">17429412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo D.G., Sung Y.-H., Hellem T.L., Fiedler K.K., Shi X., Jeong E.-K., Renshaw P.F. Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: A 31-phosphorus magnetic resonance spectroscopy study. J. Affect. Disord. 2011;135:354&#x2013;361. doi: 10.1016/j.jad.2011.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2011.07.010</ArticleId><ArticleId IdType="pmc">PMC4641570</ArticleId><ArticleId IdType="pubmed">21831448</ArticleId></ArticleIdList></Reference><Reference><Citation>Roitman S., Green T., Osher Y., Karni N., Levine J. Creatine monohydrate in resistant depression: A preliminary study. Bipolar Disord. 2007;9:754&#x2013;758. doi: 10.1111/j.1399-5618.2007.00532.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5618.2007.00532.x</ArticleId><ArticleId IdType="pubmed">17988366</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo R.A., Silva M., Fernandes F.d.B.F., Amaral J.A.d.M.S., Dias R.d.S., Lafer B. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression. J. Neural. Transm. 2018;125:247&#x2013;257. doi: 10.1007/s00702-017-1817-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-017-1817-5</ArticleId><ArticleId IdType="pmc">PMC5775367</ArticleId><ArticleId IdType="pubmed">29177955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kious B.M., Kondo D.G., Renshaw P.F. Creatine for the Treatment of Depression. Biomolecules. 2019;9:406. doi: 10.3390/biom9090406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9090406</ArticleId><ArticleId IdType="pmc">PMC6769464</ArticleId><ArticleId IdType="pubmed">31450809</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazini F.L., Cunha M.P., Rodrigues A.L.S. The possible beneficial effects of creatine for the management of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2019;89:193&#x2013;206. doi: 10.1016/j.pnpbp.2018.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2018.08.029</ArticleId><ArticleId IdType="pubmed">30193988</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo D.G., Forrest L.N., Shi X., Sung Y.-H., Hellem T.L., Huber R.S., Renshaw P.F. Creatine target engagement with brain bioenergetics: A dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression. Amino Acids. 2016;48:1941&#x2013;1954. doi: 10.1007/s00726-016-2194-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-016-2194-3</ArticleId><ArticleId IdType="pmc">PMC4974294</ArticleId><ArticleId IdType="pubmed">26907087</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Anci K.E., Allen P.J., Kanarek R.B. A potential role for creatine in drug abuse? Mol. Neurobiol. 2011;44:136&#x2013;141. doi: 10.1007/s12035-011-8176-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-011-8176-2</ArticleId><ArticleId IdType="pubmed">21399936</ArticleId></ArticleIdList></Reference><Reference><Citation>Amital D., Vishne T., Roitman S., Kotler M., Levine J. Open Study of Creatine Monohydrate in Treatment-Resistant Posttraumatic Stress Disorder. J. Clin. Psychiatry. 2006;67:836&#x2013;837. doi: 10.4088/JCP.v67n0521c.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.v67n0521c</ArticleId><ArticleId IdType="pubmed">16841637</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen P.J. Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value? Neurosci. Biobehav. Rev. 2012;36:1442&#x2013;1462. doi: 10.1016/j.neubiorev.2012.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2012.03.005</ArticleId><ArticleId IdType="pmc">PMC3340488</ArticleId><ArticleId IdType="pubmed">22465051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal T.C., Majeroni B.A., Pretorius R., Malik K. Fatigue: An overview. Am. Fam. Physician. 2008;78:1173&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pubmed">19035066</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal G.A., Hansen S. Post-Viral Fatigue Syndrome: Evidence for Underlying Organic Disturbance in the Muscle Fibre. Eur. Neurol. 1989;29:273&#x2013;276. doi: 10.1159/000116426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000116426</ArticleId><ArticleId IdType="pubmed">2792146</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards R.H.T., Newham D.J., Peters T.J. Muscle biochemistry and pathophysiology in postviral fatigue syndrome. Br. Med. Bull. 1991;47:826&#x2013;837. doi: 10.1093/oxfordjournals.bmb.a072514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.bmb.a072514</ArticleId><ArticleId IdType="pubmed">1794087</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane R.J.M., Barrett M.C., Taylor D.J., Kemp G.J., Lodi R. Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle. Neuromuscul. Disord. 1998;8:204&#x2013;209. doi: 10.1016/S0960-8966(98)00021-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-8966(98)00021-2</ArticleId><ArticleId IdType="pubmed">9631403</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan W.M.H., More I.A.R., Behan P.O. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. 1991;83:61&#x2013;65. doi: 10.1007/BF00294431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00294431</ArticleId><ArticleId IdType="pubmed">1792865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Baumer A., Mackay I.R., Linnane A.W., Nagley P. Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome. Hum. Mol. Genet. 1995;4:751&#x2013;754. doi: 10.1093/hmg/4.4.751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/4.4.751</ArticleId><ArticleId IdType="pubmed">7633428</ArticleId></ArticleIdList></Reference><Reference><Citation>Filler K., Lyon D., Bennett J., McCain N., Elswick R., Lukkahatai N., Saligan L.N. Association of mitochondrial dysfunction and fatigue: A review of the literature. BBA Clin. 2014;1:12&#x2013;23. doi: 10.1016/j.bbacli.2014.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbacli.2014.04.001</ArticleId><ArticleId IdType="pmc">PMC4136529</ArticleId><ArticleId IdType="pubmed">25147756</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Maes M. Mitochondrial dysfunctions in Myalgic Encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab. Brain Dis. 2014;29:19&#x2013;36. doi: 10.1007/s11011-013-9435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-013-9435-x</ArticleId><ArticleId IdType="pubmed">24557875</ArticleId></ArticleIdList></Reference><Reference><Citation>Malatji B.G., Meyer H., Mason S., Engelke U.F.H., Wevers R.A., Van Reenen M., Reinecke C.J. A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controls. BMC Neurol. 2017;17:88. doi: 10.1186/s12883-017-0863-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0863-9</ArticleId><ArticleId IdType="pmc">PMC5426044</ArticleId><ArticleId IdType="pubmed">28490352</ArticleId></ArticleIdList></Reference><Reference><Citation>Derakhshan M. Viral infection, a suggestive hypothesis for aetiology of chronic fatigue syndrome. J. Med. Hypotheses Ideas. 2008;2:10&#x2013;11.</Citation></Reference><Reference><Citation>Smith A.P. Post-viral Fatigue: Implications for Long Covid. Asian J. Res. Infect. Dis. 2021:17&#x2013;23. doi: 10.9734/ajrid/2021/v6i130182.</Citation><ArticleIdList><ArticleId IdType="doi">10.9734/ajrid/2021/v6i130182</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x2018;The long tail of Covid-19&#x2019;-The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2021;9:1349. doi: 10.12688/f1000research.27287.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.2</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Ther. Adv. Infect. 2021;8:20499361211009385. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostojic S.M., Stojanovic M., Drid P., Hoffman J.R., Sekulic D., Zenic N. Supplementation with Guanidinoacetic Acid in Women with Chronic Fatigue Syndrome. Nutrients. 2016;8:72. doi: 10.3390/nu8020072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8020072</ArticleId><ArticleId IdType="pmc">PMC4772036</ArticleId><ArticleId IdType="pubmed">26840330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostojic S.M. Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome. Nutrients. 2021;13:503. doi: 10.3390/nu13020503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020503</ArticleId><ArticleId IdType="pmc">PMC7913646</ArticleId><ArticleId IdType="pubmed">33557013</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>